Back to search

Article

A network pharmacology analysis on drug-like compounds from Ganoderma lucidum for alleviation of Atherosclerosis

2021-02-26

Abstract excerpt

<h4>Background: </h4> Ganoderma lucidum (GL) is known as a potent alleviator against chronic inflammatory disease like atherosclerosis (AS), but its critical bioactive compounds and their mechanisms against AS have not been unveiled. This research aimed to identify the key compounds(s) and mechanism(s) of GL against AS through network pharmacology. <h4>Methods: </h4>: The compounds from GL were identified by gas c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86d8043e-fbee-5d86-bf14-c28ff8b4cf63
DOI
10.21203/rs.3.rs-236410/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A network pharmacology analysis on drug-like compounds from Ganoderma lucidum for alleviation of AtherosclerosisDOI 10.21203/rs.3.rs-236410/v1
Select a neighboring publication to make it the new centre.